November 7, 2018 08:11 AM EST
Bioregnum
Opinion

Bound to the hip with Trump, ex-Cel­gene chief Bob Hug­in gets whipped in New Jer­sey Sen­ate race

This wasn’t Bob Hug­in’s year to start a new ca­reer in pol­i­tics.

The ex-Cel­gene ex­ec, wide­ly laud­ed in the in­vest­ment com­mu­ni­ty for the com­pa­ny’s fast …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times